Jane Huang - Nov 17, 2021 Form 4 Insider Report for BeiGene, Ltd. (BGNE)

Signature
/s/ Qing Nian, as Attorney-in-Fact
Stock symbol
BGNE
Transactions as of
Nov 17, 2021
Transactions value $
-$392,063
Form type
4
Date filed
11/19/2021, 05:18 PM
Previous filing
Oct 21, 2021
Next filing
Dec 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BGNE American Depositary Shares Options Exercise $180K +1.5K $119.96 1.5K Nov 17, 2021 Direct F1
transaction BGNE American Depositary Shares Sale -$75.2K -200 -13.33% $376.16 1.3K Nov 17, 2021 Direct F1, F2, F3
transaction BGNE American Depositary Shares Sale -$113K -300 -23.08% $377.14 1K Nov 17, 2021 Direct F1, F2, F4
transaction BGNE American Depositary Shares Sale -$37.8K -100 -10% $377.92 900 Nov 17, 2021 Direct F1, F2
transaction BGNE American Depositary Shares Sale -$38K -100 -11.11% $379.88 800 Nov 17, 2021 Direct F1, F2, F5
transaction BGNE American Depositary Shares Sale -$76.3K -200 -25% $381.41 600 Nov 17, 2021 Direct F1, F2
transaction BGNE American Depositary Shares Sale -$38.2K -100 -16.67% $382.42 500 Nov 17, 2021 Direct F1, F2
transaction BGNE American Depositary Shares Sale -$38.4K -100 -20% $384.16 400 Nov 17, 2021 Direct F1, F2
transaction BGNE American Depositary Shares Sale -$38.5K -100 -25% $385.28 300 Nov 17, 2021 Direct F1, F2
transaction BGNE American Depositary Shares Sale -$116K -300 -100% $387.94 0 Nov 17, 2021 Direct F1, F2, F6
holding BGNE Ordinary Shares 145K Nov 17, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BGNE Share Option (Right to Buy) Options Exercise $0 -19.5K -7.79% $0.00 231K Nov 17, 2021 Ordinary Shares 19.5K $9.23 Direct F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each American Depositary Share represents 13 Ordinary Shares.
F2 The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 17, 2018, as most recently amended on December 15, 2020.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $375.76 to $376.55, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $376.89 to $377.37, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $379.61 to $380.44, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $387.82 to $388.00, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F7 The number of securities underlying the option and the exercise price therefor are represented in ordinary shares.
F8 These securities vest over a four-year period as follows: 25% on June 5, 2020, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control.